Cargando…
A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells
Bladder cancer (BLCA) remains a difficult malignancy to manage because of its high recurrence, intense follow-up, and invasive diagnostic and treatment techniques. Immune checkpoint inhibitors (ICIs) have forged a new direction for the treatment of BLCA, but it is currently challenging to predict wh...
Autores principales: | Wang, Jiaqi, Zhu, Jiying, Hu, Junchi, Wang, Ziruoyu, Wang, Xiaobo, Pan, Jianbo, Chu, Yiwei, Li, Zengxia, Jiang, Wei, Liang, Chunmin, Hou, Jun, Guo, Jianming, Dang, Yongjun, Jiang, Shuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405094/ https://www.ncbi.nlm.nih.gov/pubmed/37554182 http://dx.doi.org/10.1016/j.gendis.2022.10.022 |
Ejemplares similares
-
Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells
por: Wang, Ziruoyu, et al.
Publicado: (2023) -
Continuous culture of urine-derived bladder cancer cells for precision medicine
por: Jiang, Shuai, et al.
Publicado: (2019) -
Nucleolus localization of SpyCas9 affects its stability and interferes with host protein translation in mammalian cells
por: Tan, Renke, et al.
Publicado: (2020) -
Urine ketone bodies and adverse outcomes in patients with acute ischemic stroke or TIA()
por: Wang, Anxin, et al.
Publicado: (2022) -
Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma
por: Doroud, Delaram, et al.
Publicado: (2022)